Full Press Release Details
With JUVÉDERM ® VOLUX™ XC, You Can Receive Non-Surgical Jawline Augmentation in Your Aesthetic Provider's Office
IRVINE, Calif. , Jan. 18, 2023 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), announced the highly anticipated national launch of JUVÉDERM ® VOLUX™ XC. The long-lasting hyaluronic acid (HA) filler is now available at aesthetic practices for consumers over the age of 21 with moderate to severe loss of jawline definition. 1
"With 40% of aesthetically-aware consumers considering treatment in the next year to their jawline or jowls with dermal filler, 2* Allergan Aesthetics is excited to address this need by offering JUVÉDERM ® VOLUX™ XC, a specifically designed and well-researched solution," said Carrie Strom , President, Global Allergan Aesthetics and Senior Vice President, AbbVie . "As the category leader, we continue to innovate by providing aesthetic specialists and patients the broadest portfolio of differentiated fillers." 1,3-7
"Many different types of patients can benefit from JUVÉDERM ® VOLUX™ XC whether you want to address the appearance of jowls or the contour of the jawline," said Dr. Sachin Shridharani , board-certified plastic surgeon. 1 "With the addition of this new dermal filler to the JUVÉDERM ® Collection, I can create a smooth, natural-looking, and long-lasting contour that lasts up to twelve months with optimal treatment." 1
JUVÉDERM ® VOLUX™ XC is the newest member of the JUVÉDERM ® Collection, and offers a minimally invasive, non-surgical treatment option with minimal downtime. 1 In the JUVÉDERM ® VOLUX™ XC clinical trial, patients reported high satisfaction with the results of their treatment. 1 The JUVÉDERM ® Collection is the number one chosen dermal filler collection in the U.S. 8 † Additionally, in a survey of aesthetic providers with experience using three or more dermal filler brands, the JUVÉDERM ® brand was preferred over two times more than other dermal filler brands. 9‡
Commonly reported side effects in the clinical study included tenderness, lumps/bumps, pain, swelling, firmness, bruising, redness, itching, and discoloration at the injection sites, as reported in their 30-day daily diaries. 1 These side effects are consistent with HA filler injections and were usually mild (causing little discomfort and no effect on daily activities) or moderate (causing some discomfort and effect on daily activities) in severity. 1 Most of these side effects went away on their own within two weeks. 1
Consumers and new patients who receive aesthetic treatment from the JUVÉDERM ® Collection of Fillers, can also enroll in Allē, the Allergan Aesthetics loyalty rewards program to unlock access to curated content, exclusive offers, and personalized rewards that can be used for savings on the Allergan Aesthetics portfolio of products and redeemed at a participating provider's office, subject to applicable program terms and conditions. Allē is the first and only loyalty program in the aesthetics market to also offer consumers the ability to earn points on over 40 non-Allergan Aesthetics treatments and brands.
For more information on the JUVÉDERM ® Collection of Fillers, visit Juvederm.com and follow @JUVEDERM on Instagram.
About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.AllerganAesthetics.com .
About AbbVie AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on Twitter , Facebook , Instagram , YouTube and LinkedIn .
JUVÉDERM ® Injectable Gel Fillers Important Information
JUVÉDERM ® VOLUX™ XC injectable gel is for deep injection to improve moderate to severe loss of jawline definition in adults over the age of 21.
JUVÉDERM ® VOLUMA ® XC injectable gel is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to improve the chin profile in adults over 21.
JUVÉDERM ® VOLLURE ® XC, JUVÉDERM ® Ultra Plus XC, and JUVÉDERM ® Ultra XC injectable gels are for injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. JUVÉDERM ® VOLLURE ® XC injectable gel is for adults over 21.
JUVÉDERM ® Ultra XC injectable gel is also for injection into the lips and perioral area for lip augmentation in adults over 21.
JUVÉDERM ® VOLBELLA® XC injectable gel is for injection into the lips for lip augmentation and correction of perioral lines, and for injection into the undereye hollows to improve the appearance of undereye hollows in adults over the age of 21.
IMPORTANT SAFETY INFORMATION
Are there any reasons why I should not receive any JUVÉDERM ® formulation?
Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), if you are allergic to lidocaine or the Gram-positive bacterial proteins used in these products, or if you have had previous allergic reactions to hyaluronic acid fillers.
What warnings should my doctor advise me about?
What precautions should my doctor advise me about?
What are possible side effects of treatment?
The most commonly reported side effects with JUVÉDERM ® injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM ® VOLBELLA ® XC, dryness was also reported.
These side effects are consistent with other facial injection procedures and most will resolve within 30 days. Your doctor may choose to treat side effects persisting longer with antibiotics, steroids, or hyaluronidase (an enzyme that breaks down hyaluronic acid).
As with all skin injection procedures, there is a risk of infection.
To report a side effect with any product in the JUVÉDERM ® Collection, please call the Allergan ® Product Support Department at 1-877-345-5372. Please also visit Juvederm.com or talk to your doctor for more information.
Products in the JUVÉDERM ® Collection are available only by a licensed physician or properly licensed practitioner.
* ASAPS Practice Survey Data, 2019 (N = 331) 2 † Based on 2022 Market Research Data 3 ‡ Based on a quantitative survey fielded in May- June 2022 (n=354). Participants were current injectors of JUVÉDERM ® fillers and must have used at least two other aesthetic dermal fillers from two separate aesthetics companies